Edgar Tracker

ABT ABBOTT LABORATORIES

NYSE · CIK 1800 · Pharmaceutical Preparations

SEC company page

Public articles

ABT · 8-K

Filing note · 8-K · filed 2026-10-21

Abbott Plans to Separate $8.5 Billion Nutrition Business by End of 2027 What Happened Abbott Laboratories disclosed plans to separate its global Nutrition business into an indepen…

Recent filings

–

Form Filed Title Accession
8-K2026-10-218.01 Other Events · 9.01 Financial Statements and Exhibits Article0001104659-26-117587
8-K2026-10-212.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001628280-26-066601
8-K2026-08-207.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and Exhibits0001104659-26-099247
10-Q2026-07-2810-Q0001628280-26-050134
8-K2026-07-162.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001628280-26-048377
11-K2026-06-1811-K0001104659-26-075724
SD2026-05-27FORM SD0001104659-26-066986
SCHEDULE 13G2026-04-29—0002100119-26-000151
10-Q2026-04-2910-Q0001628280-26-028357
32026-04-28—0001306119-26-000002
8-K2026-04-275.02 Departure/Election of Directors or Principal Officers · 5.03 Amendments to Articles of Incorporation or Bylaws · 5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits0001104659-26-049434
S-82026-04-24FORM S-80001104659-26-048560
8-K2026-04-178.01 Other Events · 9.01 Financial Statements and Exhibits0001104659-26-044892
8-K2026-04-162.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001628280-26-025365
SCHEDULE 13G/A2026-03-26—0000102909-26-000500
32026-03-25—0001263312-26-000003
S-82026-03-23FORM S-80001104659-26-033413
8-K2026-03-238.01 Other Events · 9.01 Financial Statements and Exhibits0001104659-26-033079
ARS2026-03-13ANNUAL REPORT TO SECURITY HOLDERS0001308179-26-000066
DEFA14A2026-03-13DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS0001308179-26-000065